Prospera Financial Services’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$497K Sell
1,282
-123
-9% -$45.6K 0.01% 1039
2026
Q1
$413K Buy
1,405
+158
+13% +$51.9K 0.01% 1080
2025
Q4
$439K Sell
1,247
-53
-4% -$17.9K 0.01% 972
2025
Q3
$422K Sell
1,300
-4,112
-76% -$1.28M 0.01% 1008
2025
Q2
$2.11M Buy
5,412
+4,168
+335% +$1.68M 0.04% 453
2025
Q1
$544K Buy
1,244
+11
+0.9% +$4.42K 0.01% 752
2024
Q4
$457K Buy
1,233
+8
+0.7% +$3.35K 0.01% 768
2024
Q3
$640K Sell
1,225
-6
-0.5% -$3.21K 0.02% 636
2024
Q2
$669K Buy
1,231
+9
+0.7% +$4.76K 0.02% 611
2024
Q1
$635K Buy
1,222
+84
+7% +$41.8K 0.02% 623
2023
Q4
$537K Sell
1,138
-15
-1% -$6.94K 0.02% 636
2023
Q3
$503K Buy
1,153
+76
+7% +$34.5K 0.02% 612
2023
Q2
$480K Sell
1,077
-193
-15% -$89K 0.02% 633
2023
Q1
$585K Hold
1,270
0.02% 566
2022
Q4
$652K Buy
1,270
+223
+21% +$113K 0.03% 465
2022
Q3
$477K Buy
1,047
+468
+81% +$224K 0.02% 534
2022
Q2
$280K Buy
579
+53
+10% +$26.2K 0.01% 649
2022
Q1
$259K Sell
526
-19
-3% -$8.69K 0.01% 789
2021
Q4
$253K Sell
545
-582
-52% -$245K 0.01% 752
2021
Q3
$420K Buy
1,127
+162
+17% +$61.6K 0.02% 579
2021
Q2
$369K Sell
965
-69
-7% -$26.4K 0.02% 608
2021
Q1
$371K Sell
1,034
-11
-1% -$3.54K 0.02% 562
2020
Q4
$337K Buy
1,045
+1,034
+9,400% +$317K 0.02% 505
2020
Q3
$3K Buy
+11
New +$2.96K ﹤0.01% 1376
2018
Q1
Sell
-1,040
Closed -$239K 446
2017
Q4
$239K Buy
+1,040
New +$222K 0.04% 349

Other funds holding ELV

Prospera Financial Services's ELV Position: Q2 2026 in Review

Prospera Financial Services reduced its Elevance Health (ELV) stake by 8.8% in Q2 2026, selling an estimated $45.6K and leaving 1,282 shares worth $497K. The position accounts for 0.01% of the portfolio, ranked #1039.

Prospera Financial Services first reported a position in ELV in Q4 2017 and has held it in 25 quarters since. The position peaked at $2.11M in Q2 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Prospera Financial Services held 1,282 shares of Elevance Health worth $497K as of Q2 2026.
  • Prospera Financial Services sold 123 Elevance Health shares in Q2 2026, an estimated $45.6K.
  • Elevance Health made up 0.01% of Prospera Financial Services's portfolio in Q2 2026, its #1039 holding.
  • Prospera Financial Services first reported a position in Elevance Health in Q4 2017 and has held it in 25 quarters since.
  • Prospera Financial Services's Elevance Health position peaked at $2.11M in Q2 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Prospera Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.